VEGFA and neoplasm: However, preclinical work suggests that complete blockade of angiogenesis with high doses of anti-VEGF drugs may increase tumoral hypoxia and create an immunosuppressive environment within the tumour mediated by Ly6Clow monocytes and Ly6G+ neutrophils16–18.